Advertisement Inergetics enters second phase development of CBD-based supplements - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Inergetics enters second phase development of CBD-based supplements

Inergetics, a leading developer of nutritional supplements, has announced the beginning of the second phase of development towards the launch of its proprietary line of natural cannabidiol (CBD)-based nutritional supplements it is developing in partnership with Terra Tech.

Bioavailability is an important measurement of how efficiently a substance is taken into the body. Published scientific studies report CBD oral bioavailability in the range of between 10 – 20%. Efforts to increase its bioavailability and therapeutic benefits in the body is a major point of differentiation to CBD products.

To assess bioavailability, pharmacokinetic (PK) studies are conducted to help describe what the body does to an ingested substance and its movement throughout the body. This testing is an important step to establish absorption and efficacy of a substance.

"Enhancing oral absorption and how quickly CBD gets into the bloodstream is but one of the challenges for the industry. A PK study is underway in collaboration with our international R&D alliances using new technology applied to our CBD – a technology that is well proven especially with lipid soluble nutrients," states Chief Science Officer Carl Germano, RD, CNS, CDN.

"We are confident the outcome will result in a product that sets the gold standard for efficiency and effectiveness as compared to what exists in the marketplace today."

In addition to improving oral bioavailability of CBD, Inergetics goal is to enhance its formulations with other dietary sources of cannabinoids that complement CBD. Through its international R&D alliances, successful procurement of an additional cannabinoid that serves as a counterpart to CBD’s effects in the body has been obtained and will be a vital component to the finalized formulas.

"These R&D efforts provide for the innovation necessary to help us gain a competitive advantage and sustain long-run growth of our company," states Michael James, CEO.

"In addition to our distribution and brand building initiatives to address customer demands and market competition, we will continue to nurture our R&D strengths to focus on new manufacturing technologies and processes that result in significant product improvements."